Latest Insider Transactions at Anika Therapeutics, Inc. (ANIK)
This section provides a real-time view of insider transactions for Anika Therapeutics, Inc. (ANIK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Anika Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Anika Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2022
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+33.02%
|
-
|
|
Jun 08
2022
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+25.34%
|
-
|
|
Jun 08
2022
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+25.03%
|
-
|
|
Jun 08
2022
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+27.06%
|
-
|
|
Jun 08
2022
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,954
+25.07%
|
-
|
|
May 11
2022
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Open market or private purchase
|
Direct |
1,500
+13.2%
|
$31,500
$21.37 P/Share
|
|
Apr 26
2022
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,576
+25.23%
|
-
|
|
Mar 14
2022
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Open market or private purchase
|
Direct |
1,500
+15.2%
|
$39,000
$26.65 P/Share
|
|
Mar 11
2022
|
Jeffery S Thompson Director |
BUY
Open market or private purchase
|
Direct |
2,000
+10.46%
|
$48,000
$24.66 P/Share
|
|
Mar 11
2022
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Open market or private purchase
|
Direct |
4,000
+20.08%
|
$96,000
$24.62 P/Share
|
|
Mar 11
2022
|
Cheryl R Blanchard President, CEO, Director |
BUY
Open market or private purchase
|
Direct |
8,100
+6.53%
|
$202,500
$25.59 P/Share
|
|
Mar 09
2022
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,420
+21.75%
|
-
|
|
Mar 09
2022
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,081
-13.6%
|
$28,106
$26.22 P/Share
|
|
Mar 09
2022
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
3,682
+31.66%
|
-
|
|
Mar 09
2022
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
748
-2.95%
|
$19,448
$26.22 P/Share
|
|
Mar 09
2022
|
Thomas Finnerty EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,548
+9.13%
|
-
|
|
Mar 09
2022
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,438
+27.12%
|
-
|
|
Mar 04
2022
|
David Colleran EVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-14.68%
|
$22,754
$31.06 P/Share
|
|
Mar 04
2022
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+33.33%
|
-
|
|
Feb 26
2022
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-3.72%
|
$28,192
$32.13 P/Share
|
|
Feb 26
2022
|
Thomas Finnerty EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+11.24%
|
-
|
|
Feb 25
2022
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-3.87%
|
$26,624
$32.13 P/Share
|
|
Feb 25
2022
|
Thomas Finnerty EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,834
+11.64%
|
-
|
|
Feb 09
2022
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
3,149
-14.43%
|
$94,470
$30.72 P/Share
|
|
Feb 09
2022
|
Thomas Finnerty EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
10,125
+31.69%
|
-
|
|
Oct 28
2021
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,179
+50.0%
|
-
|
|
Aug 12
2021
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Open market or private purchase
|
Direct |
777
+9.4%
|
$31,080
$40.2 P/Share
|
|
Aug 11
2021
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Open market or private purchase
|
Direct |
2,850
+29.81%
|
$114,000
$40.21 P/Share
|
|
Aug 10
2021
|
Michael L Levitz EVP, CFO, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,859
+50.0%
|
-
|
|
Jul 08
2021
|
James Loerop EVP Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
731
-11.56%
|
$31,433
$43.24 P/Share
|
|
Jul 08
2021
|
James Loerop EVP Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+32.18%
|
-
|
|
Jun 16
2021
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+21.23%
|
-
|
|
Jun 16
2021
|
Raymond J Land Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+25.6%
|
-
|
|
Jun 16
2021
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+20.82%
|
-
|
|
Jun 16
2021
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+23.63%
|
-
|
|
Jun 16
2021
|
Jeffery S Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+21.62%
|
-
|
|
Jun 16
2021
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+20.86%
|
-
|
|
Jun 15
2021
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,994
+7.4%
|
$98,802
$33.4 P/Share
|
|
May 18
2021
|
John B Henneman Iii Director |
BUY
Open market or private purchase
|
Direct |
2,000
+15.03%
|
$84,000
$42.86 P/Share
|
|
May 12
2021
|
Raymond J Land Director |
SELL
Open market or private sale
|
Direct |
2,000
-20.09%
|
$84,000
$42.6 P/Share
|
|
Apr 26
2021
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,575
+41.62%
|
-
|
|
Mar 04
2021
|
David Colleran EVP, General Counsel, Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
-
|
|
Feb 26
2021
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-7.0%
|
$32,597
$37.57 P/Share
|
|
Feb 26
2021
|
Thomas Finnerty EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+19.25%
|
-
|
|
Feb 25
2021
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
832
-7.99%
|
$30,784
$37.39 P/Share
|
|
Feb 25
2021
|
Thomas Finnerty EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+21.39%
|
-
|
|
Feb 25
2021
|
James Loerop EVP Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,567
+32.05%
|
-
|
|
Nov 10
2020
|
Raymond J Land Director |
SELL
Open market or private sale
|
Direct |
3,446
-25.72%
|
$124,056
$36.77 P/Share
|
|
Oct 30
2020
|
Thomas Finnerty EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
666
-8.08%
|
$21,312
$32.62 P/Share
|